Your browser doesn't support javascript.
loading
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study.
Lonardi, Sara; Prete, Alessandra Anna; Morano, Federica; Messina, Marco; Formica, Vincenzo; Corsi, Domenico Cristiano; Orciuolo, Corrado; Frassineti, Giovanni Luca; Zampino, Maria Giulia; Casagrande, Mariaelena; Masi, Gianluca; Ronzoni, Monica; Scartozzi, Mario; Buonadonna, Angela; Mosconi, Stefania; Ratti, Margherita; Sartore-Bianchi, Andrea; Tamburini, Emiliano; Prisciandaro, Michele; Bergamo, Francesca; Spada, Massimiliano; Corallo, Salvatore; Vettore, Valentina; Loupakis, Fotios; Fassan, Matteo; Del Bianco, Paola; Zagonel, Vittorina; Pietrantonio, Filippo.
Afiliação
  • Lonardi S; Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Department of Oncology 1, veneto Institute of Oncology IOV-IRCCS, Padua, Italy sara.lonardi@iov.veneto.it.
  • Prete AA; Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Department of Oncology 1, veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Messina M; Department of Oncology, Fondazione Istituto G. Giglio, Cefalù, Italy.
  • Formica V; Medical Oncology Unit, Policlinico Tor Vergata, Rome, Italy.
  • Corsi DC; Medical Oncology Unit, Ospedale San Giovanni Calibita Fatebenefratelli, Rome, Italy.
  • Orciuolo C; Oncology Unit, Department of Radiology, Oncology and Human Pathology, Sapienza University of Roma, Rome, Italy.
  • Frassineti GL; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori (IRST), Meldola, Italy.
  • Zampino MG; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology-IRCCS, Milan, Italy.
  • Casagrande M; Department of Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Masi G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Ronzoni M; Division of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Scartozzi M; Oncologia Medica, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Buonadonna A; Department of Medical Oncology, University of Cagliari, Cagliari, Italy.
  • Mosconi S; Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy.
  • Ratti M; Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Sartore-Bianchi A; Division of Oncology, Hospital Trust of Cremona, Cremona, Italy.
  • Tamburini E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Prisciandaro M; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.
  • Bergamo F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Spada M; Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Department of Oncology 1, veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Corallo S; Department of Oncology, Fondazione Istituto G. Giglio, Cefalù, Italy.
  • Vettore V; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Loupakis F; Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Department of Oncology 1, veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Fassan M; Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Department of Oncology 1, veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Del Bianco P; Department of Medicine (DIMED), Pathology Unit, University of Padua, Padua, Veneto, Italy, University of Padova, Padova, Veneto, Italy.
  • Zagonel V; Veneto Institute of Oncology, IOV-IRCCS, Padua, Veneto, Italy.
  • Pietrantonio F; Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
J Immunother Cancer ; 9(11)2021 11.
Article em En | MEDLINE | ID: mdl-34815354
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Cetuximab Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Cetuximab Idioma: En Ano de publicação: 2021 Tipo de documento: Article